Mayur Sarangdhar, PhD, MRes
Mayur Sarangdhar, PhD, MRes
Verified email at cchmc.org - Homepage
Title
Cited by
Cited by
Year
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data
M Sarangdhar, S Tabar, C Schmidt, A Kushwaha, K Shah, JE Dahlquist, ...
Nature biotechnology 34 (7), 697-700, 2016
362016
Dipeptidyl peptidase‐4 inhibitors moderate the risk of genitourinary tract infections associated with sodium‐glucose co‐transporter‐2 inhibitors
GP Fadini, BM Bonora, S Mayur, M Rigato, A Avogaro
Diabetes, Obesity and Metabolism 20 (3), 740-744, 2018
352018
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
GP Fadini, M Sarangdhar, A Avogaro
BMJ Open Diabetes Research and Care 6 (1), e000475, 2018
212018
Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
GP Fadini, M Sarangdhar, F De Ponti, A Avogaro, E Raschi
BMJ Open Diabetes Research and Care 7 (1), e000725, 2019
152019
Pharmacovigilance evaluation of the association between DPP-4 inhibitors and heart failure: stimulated reporting and moderation by drug interactions
GP Fadini, M Sarangdhar, A Avogaro
Diabetes Therapy 9 (2), 851-861, 2018
142018
Spiking Neurons: Is coincidence-factor enough for comparing responses with fluctuating membrane voltage?
C Kambhampati
Proceedings of the World Congress on Engineering 2, 2008
102008
Spiking Neurons and Synaptic Stimuli: Neural Response Comparison Using Coincidence-Factor
M Sarangdhar, C Kambhampati
Advances in Electrical Engineering and Computational Science, 681-692, 2009
62009
Spiking Neurons and Synaptic Stimuli: Determining the Fidelity of Coincidence-Factor in Neural Response Comparison.
M Sarangdhar, C Kambhampati
Engineering Letters 16 (4), 2008
62008
A numerical model for Hodgkin-Huxley neural stimulus reconstruction
M Sarangdhar, C Kambhampati
IAENG International Journal of Computer Science 38 (1), 89-94, 2011
52011
Using systems biology-based analysis approaches to identify mechanistically significant adverse drug reactions: Pulmonary complications from combined use of anti-TNFα agents …
M Sarangdhar, A Kushwaha, J Dahlquist, A Jegga, B Aronow
AMIA Summits on Translational Science Proceedings 2013, 151, 2013
42013
System and method for data mining very large drugs and clinical effects databases
B Aronow, M Sarangdhar, SC Tabar, AG Jegga
US Patent 10,769,242, 2020
32020
Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors: data from the United States Food and Drug Administration adverse event reporting system
XN Pundole, M Sarangdhar, ME Suarez-Almazor
Journal of Immunotherapy and Precision Oncology 2 (3), 65-73, 2019
32019
The impact of marijuana on antidepressant treatment in adolescents: clinical and pharmacologic considerations
SE Vaughn, JR Strawn, EA Poweleit, M Sarangdhar, LB Ramsey
Journal of personalized medicine 11 (7), 615, 2021
22021
Network analyses of biomedical and genomic big data
M Sarangdhar, RC Gudivada, RB Shrestha, Y Wang, AG Jegga
Big Data of Complex Networks, 13-36, 2016
22016
Predicting Drug Response and Novel Therapeutic Candidates Using Signatures of Molecular Alterations in Hematologic Malignancies
G Labilloy, E O'Brien, B VanCauwenbergh, L Byerly, M Basu, W Seibel, ...
Blood 132, 2219, 2018
12018
OP0197 Rheumatic and musculoskeletal adverse events associated with immune checkpoint inhibitors: data mining of the us food and drug administration adverse event reporting system
X Pundole, M Sarangdhar, ME Suarez-Almazor
Annals of the Rheumatic Diseases 77 (Suppl 2), 147-148, 2018
12018
High-density data mining to identify unique toxicities of adolescent/young adult cancer treatment: a Report from the Children's Oncology Group
M Sarangdhar, SL Whiteway, JL Heath, EA Raetz, E Hibbits, M Devidas, ...
Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2562 …, 2017
12017
Pharmacogenomic prediction of treatment-induced severe lung toxicity in Hodgkin lymphoma (HL).
R Karns, M Sarangdhar, B Aronow, M Basu, CL Schwartz, KM Kelly, ...
Journal of Clinical Oncology 34 (15_suppl), 7522-7522, 2016
12016
Next generation sequencing (NGS) to identify targetable recurring mutations and exceptional responders in relapsed and high-risk childhood and adolescent/young adult (AYA …
B Turpin, R Karns, M Sarangdhar, BD Weiss, JI Geller, M Absalon, ...
Journal of Clinical Oncology 33 (15_suppl), 11011-11011, 2015
12015
Mo1223 Lower Expression of PPARγ in AVM Tissue Provides a Novel Therapeutic Target for Use of Glitazones in Treatment of GI Bleeding: Validation of Our Large-Scale Clinical …
M Sarangdhar, AR Gruenzel, MB Yacyshyn, BJ Aronow, B Yacyshyn
Gastroenterology 148 (4), S-642, 2015
12015
The system can't perform the operation now. Try again later.
Articles 1–20